Plasma homocyst(e)ine levels and graded risk for myocardial infarction: Findings in two populations at contrasting risk for coronary heart disease

Atherosclerosis

Volumn 126, Issue 1, 1996, Pages 27-34

  Malinow, M R ^a   Ducimetiere, P ^b   Luc, G ^b   Evans, A E ^c   Arveiler, D ^d   Cambien, F ^b   Upson, B M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b INSERM   (France)

^c MONICA Project   (United Kingdom)

^d Projet MONICA Bas Rhin   (France)

Author keywords

Coronary heart disease; Myocardial infarction; Plasma homocyst(e)ine; Risk factors

Indexed keywords

HOMOCYSTEINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; GEOGRAPHY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030603998     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05890-X     Document Type: Article

References (30)

1. [1] Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation 1994;90:583.
2. [2] The WHO MONICA Project principal investigators: The World Health Organization MONICA Project (MONItoring trends and determinants in CArdiovascular disease): A major international collaboration. J Clin Epidemiol 1988;41:105.
3. [3] The WHO MONICA Project: Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Stat Q 1988;41:115.
4. [4] Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy Ph, Luc G, Richard JL, Ducimetiere P, Fruchart JC, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM study. Arteriosclerosis Thromb 1992;12:701.
5. [5] Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B. Hyperhomocystinemia; an independent risk factor for vascular disease. New Engl J Med 1991;324:1149.
6. [6] Genest JJ, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow MR. Plasma homocyst(e)ine in men with premature coronary artery disease. J Am Coll Cardiol 1990;16:1114.
7. [7] Genest JJ, McNamara JR, Upson B, Salem DN, Ordovas JM, Schaefer EJ, Malinow MR. Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. Arteriosclerosis Thromb 1991;11:1129.
8. [8] Israelsson B, Brattstrom LE, Hultberg BL. Homocysteine and myocardial infarction. Atherosclerosis 1988;71:227.
9. [9] Kang SS, Wong PWK, Cook HY, Norusis M, Messer JV. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. J Clin Invest 1986;77:1482.
10. [10] Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991;48:536.
11. [11] Malinow MR, Sexton G, Averbuch M, Grossman M, Wilson D, Upson B. Homocyst(e)inemia in daily practice: levels in coronary artery disease. Coronary Artery Dis 1990;1:215.
12. [12] Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US Physicians. J Am Med Assoc 1992;268:877.
13. [13] Murphy-Chutorian DR, Wexman MP, Brieco AJ, Heininger JA, Glassman E, Guall GE. Methionine intolerance: a possible risk factor for coronary artery disease. J Am Coll Cardiol 1985;6:725.
14. [14] Ubbink JG, Vermack WJH, Bennett JM, Becker PG, VanStaden DA, Bissbort S. The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr 1991;69:527.
15. [15] Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976;57:1079.
16. [16] Williams RR, Malinow MR, Hunt SC, Upson B, Wu LL, Hopkins PM, Stults BN, Kuida H. Hyperhomocyst(e)inemia in Utah siblings with early coronary disease. Coronary Artery Dis 1990;1:681.
17. [17] von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arteriosclerosis Thromb 1994;14:460.
18. [18] Luc G, Fruchard JC. Nouvelles methodes d'exploration des lipides. Presse Med 1994;23:1446.
19. [19] Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989;79:1180.
20. [20] Malinow MR. Homocyst(e)ine and arterial occlusive diseases. J Int Med 1994;236:603.
21. [21] Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 1989;79:139.
22. [22] Malinow MR, Levenson J, Giral P, Nieto FJ, Razavian M, Segond P, Simon A. Role of blood pressure, uric acid and hematocrit on plasma homocyst(e)ine. Atherosclerosis 1995;114-175.
23. [23] Brattstrom L, Lindgren A, Israelsson B, Malinow MR, Norrving B, Upson B. Hyperhomocysteinaemia in stroke - prevalence, cause and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992;22:214.
24. [24] Arnesen E, Refsum H, Bonaa KH. The Tromso Study: serum total homocysteine and myocardial infarction: a prospective study. Presented at the 3rd International Conference on Preventive Cardiology, Oslo, Norway, June 27-July 1, 1993. abstract.
25. [25] Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation 1993;87:1107.
26. [26] Selhub J, Jacques PF, Bostom AC, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Schaeffer EJ, Rosenberg IH. Association between plasma homocysteine levels and extracranial carotid stenosis. N Eng J Med 1995;332:286.
27. [27] Goldberg DM. Does wine work? Clin Chem 1995;41:14.
28. [28] Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 1993;270:2693.
29. [29] Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B12, vitamin B6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47.
30. [30] Brattstrom L, Israelsson B, Jeppson BL, Hultberg B. Folic acid - an innocous means of reducing plasma homocysteine. Scand J Lab Invest 1988;48:215.